-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Regenerx Biopharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2013 to Q1 2023.
- Regenerx Biopharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2023 was 144M shares, unchanged year-over-year.
- Regenerx Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 144M shares, a 3.58% increase from 2021.
- Regenerx Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 139M shares, a 3.93% increase from 2020.
- Regenerx Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 133M shares, a 1.82% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)